Navigation Links
Switzerland to stock bird flu vaccine

Switzerland has placed an order for a stock of GlaxoSmithKline Plc's experimental bird flu vaccine for human, enough to protect its entire population.//

According to the Europe’s biggest drug company, the Swiss Federal Office of Public Health had ordered 8 million doses of its H5N1 vaccine for protection against influenza pandemic which can be activated by bird flu.

After the review and approval of the regulatory file for the pre-pandemic vaccine by the Swiss regulatory agency, Swissmedic, the vaccine will be supplied and stored by near the beginning of next year.

According to Glaxo, it is in discussion with other countries in Europe on pandemic preparation plans and will file its vaccine for approval with the European Medicines Agency by the end of this year. As Glaxo’s vaccine needs a very small amount of the key ingredient, even limited supplies would be enough to vaccinate many.

The major challenge faced by the drug companies is to use the minimum amount of the active ingredient or the antigen to produce maximum number of vaccines. Though Glaxo’s vaccine is effective against the lethal H5N1 avian flu virus, its action against any mutated strain is not known.

The H5N1 strain has quickly spread beyond Asia and has claimed over 150 lives of those who were in close contact with the infected birds.

If the virus attains the ability to transmit from human to human, experts dread that it can give rise to a global epidemic of flu that could take millions of lives.

Other companies in the race to develop pandemic H5N1 vaccines are Sanofi-Aventis, Novartis AG and Baxter International Inc.
GT
'"/>




Page: 1

Related medicine news :

1. Chandy Undergoes Surgery In Switzerland
2. Bird Flu Now Spreads to Switzerland
3. Number Of Bird Flu Cases In Switzerland Reaches 11
4. Risk of deep vein thrombosis less in people who were flight stockings when flying
5. Health and Human Services stockpiles 20 million bird flu Vaccines
6. Rich countries stock piling anti flu drugs with no stocks available for poor countries
7. Bird flu: the threat causes lowering in poultry stocks
8. Time is ripe to take stock of depression
9. Burma Restocks Poultry Farms Again
10. Depleting stock of antiretroviral drugs in Uganda raises concern
11. Companies ensure enough stock of bird flu drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... Virginia (PRWEB) , ... December 08, 2016 , ... ... services company offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care ... operations and general counsel and Eric Hoessel to vice president of sales. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... 2016 Mitsubishi Tanabe Pharma Corporation (Head Office: ... CEO: Dr. Masayuki Mitsuka ) has presented data ... edaravone intravenously in 10-14 day cycles for 48 weeks ... ALS Functional Rating Scale-Revised (ALSFRS-R). The data were presented ... in Dublin, Ireland . ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
Breaking Medicine Technology: